As of January 22, 2025, Hepion Pharmaceuticals (HEPA) has a market cap of $939,380 Dollars USD. According to our data, Hepion Pharmaceuticals is ranked No.9248 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $939,380 Dollars |
-71.28%
|
Dec 31, 2024 | $3.27 M |
-85.49%
|
Dec 29, 2023 | $22.55 M |
-46.00%
|
Dec 30, 2022 | $41.75 M |
-73.68%
|
Dec 31, 2021 | $0.16 B |
-47.95%
|
Dec 31, 2020 | $0.30 B |
-59.14%
|
Dec 31, 2019 | $0.75 B |
-72.85%
|
Dec 31, 2018 | $2.75 B |
-90.21%
|
Dec 29, 2017 | $28.06 B |
-70.00%
|
Dec 30, 2016 | $93.52 B |
-22.08%
|
Dec 31, 2015 | $120.02 B |
-30.63%
|
Dec 31, 2014 | $173.01 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Madrigal Pharmaceuticals
MDGL
|
$7.08 B |
-0.000 M
|
USA
|
Viking Therapeutics
VKTX
|
$3.79 B |
-0.000 M
|
USA
|
Galmed Pharmaceuticals
GLMD
|
$4.72 M |
0.000 M
|
Israel
|
Akero Therapeutics
AKRO
|
$1.75 B |
0.000 M
|
USA
|
Seabridge Gold
SA
|
$1.12 B |
0.000 M
|
Canada
|
89bio
ETNB
|
$0.79 B |
0.000 M
|
USA
|
Terns Pharmaceuticals
TERN
|
$0.40 B |
-0.000 M
|
USA
|
Enanta Pharmaceuticals
ENTA
|
$0.11 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Market Cap | = | HEPA Stock Price | * | HEPA Shares Outstanding |
= | $0.14 | * | 6.96 M | |
= | $939,380 Dollars |